Cover Image

亞洲的醫藥品、醫療產業 (季度更新報告)

Asia Pharmaceuticals and Healthcare Report Q1 2017

出版商 BMI Research 商品編碼 363588
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
Back to Top
亞洲的醫藥品、醫療產業 (季度更新報告) Asia Pharmaceuticals and Healthcare Report Q1 2017
出版日期: 2017年01月11日 內容資訊: 英文 35 Pages

本報告提供亞洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容


  • 亞洲市場最新形勢


  • 亞洲市場最新形勢


  • 醫藥品市場最新形勢
  • 醫療市場最新形勢


  • 亞洲:風險/利潤指標


  • 亞洲市場最新形勢


  • 亞洲市場最新形勢


  • 亞洲市場最新形勢



  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權


Product Code: 2398-1016

BMI View: Multinational pharmaceutical firms will continue to face the threat of medicine price controls in Asia. Pressures in favour of such measures will grow as governments seek to balance the need to sustain their respective universal healthcare schemes while containing costs, posing a key downside risk to our upbeat outlook to the region's pharmaceutical market. Within the region, the risk of further downward pressure is particularly acute in the developed markets of Japan and Australia, while the emerging countries that are most at risk of seeing price controls introduced will be the Philippines and Indonesia.

Healthcare Expenditure Forecasts

  • Pharmaceuticals: USD281bn in 2015 to USD305bn by 2016; 8.4% y-o-y increase in US dollar terms.
  • Healthcare: USD1,574bn in 2015 to USD1,699bn by 2016; a 8.0% y-o-y increase in US dollar terms.

Risk/Reward Index

In BMI's Pharmaceutical Q117 Risk/Reward Index (RRI), the Asia Pacific region scores 51.2 out of 100, comparing relatively well with Central and Eastern Europe (51.1), the Americas (50.6) and the Middle East and Africa (39.8) region but below Western Europe (69.3).

Table of Contents

  • BMI Industry View
    • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (Asia (Region) 2014-2020)
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data & Forecasts (Asia (Region) 2012-2020)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data & Forecasts (Asia (Region) 2012-2020)
  • Industry Risk Reward Index
  • Asia Pacific Risk/Reward Index
  • Market Overview
  • Industry Trends and Developments
  • Industry Trends And Developments
  • Regional Overview
  • Asia (Region)
    • Table: Asia pharmaceutical market (usdbn)
  • Glossary
  • Methodology
  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top